Anbio Biotechnology Class A Ordinary Shares
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NNNN research report →
Companywww.anbio.com
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets.
- CEO
- Michael Lau
- IPO
- 2025
- Employees
- 27
- HQ
- Frankfurt am Main, DE
Price Chart
Valuation
- Market Cap
- $1.40B
- P/E
- 194.45
- P/S
- 143.41
- P/B
- 46.34
- EV/EBITDA
- 214.56
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 87.06%
- Op Margin
- 66.47%
- Net Margin
- 73.75%
- ROE
- 23.00%
- ROIC
- 21.48%
Growth & Income
- Revenue
- $9.76M · 5.64%
- Net Income
- $7.23M · 169.86%
- EPS
- $0.16 · 185.71%
- Op Income
- $6.51M
- FCF YoY
- -423.93%
Performance & Tape
- 52W High
- $55.65
- 52W Low
- $7.23
- 50D MA
- $25.84
- 200D MA
- $30.57
- Beta
- 4.66
- Avg Volume
- 33.63K
Get TickerSpark's AI analysis on NNNN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Song Suki | other | 0 |
| Mar 18, 26 | Hartzler Nancy | other | 0 |
| Mar 18, 26 | LAU MICHAEL | other | 0 |
| Mar 18, 26 | TIAN CHRIS | other | 0 |
| Mar 18, 26 | XU CANY | other | 0 |
Our NNNN Coverage
We haven't published any research on NNNN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NNNN Report →